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Objectives: The aim of this study was to design and evaluate a chitosan-based
film that has properties required for successful wound dressing, and can control
drug penetration and maintenance time in the location.
Methods: Several formulations of a film containing chitosan (3%) and different
concentrations of Eudragit RL (0.5%, 1%, and 1.5%) were prepared using the
casting/solvent evaporating technique. Mechanical properties, water vapor
transmission rate (WVTR), oxygen permeability, water uptake, and nitrofurazone
permeability through the films were investigated.
Results: The study results showed that by increasing the Eudragit RL content of
composite films, their thickness and tensile strength were enhanced, while their
elongation was decreased. No significant difference was observed between the
oxygen permeability, WVTR, and water uptake results of pure chitosan films and
different composite films containing Eudragit RL. Nitrofurazone permeability of
chitosan films was increased by the inclusion of Eudragit RL in composite films,
while by increasing the concentration of Eudragit RL, the permeation rate of drug
was decreased.
Conclusion: In conclusion, addition of Eudragit RL can improve mechanical
properties of chitosan films without any undesirable effect on their water up-
take, oxygen permeability, and WVTR qualities. The permeation rate of drugs
through the composite films can be modified by changing Eudragit RL/chitosan
ratio.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
Evaluation of Chitosan/Eudragit RL Composite Film 151. Introduction
Severe skin wounds such as burn injury recover
through several disease stages, including infectious,
necrosis (and agglutination), proliferation, and
epidermis formation periods. In the infectious period,
the healing process is delayed. Wound dressings are
often used to protect wounds from infection and repair
them. Rapid healing of wounds is desirable for patients,
especially for people suffering from diabetes because
they show an extremely slow rate of healing [1e3].
Several dressings are currently used in the treatment of
burns, split graft donor sites, and chronic ulcers [4].
Unlike conventional wound dressing, which passively
provides wound protection, nowadays new types of
wound dressings are used that not only protect the
wound from surrounding environments, but also effec-
tively promote the healing process by providing an op-
timum microenvironment for healing, removing excess
of wound exudates, and allowing continuous tissue
reconstruction processes [2]. Application of an antibiotic
can be effective for suppression of bacteria, but many
drugs such as nitrofurazone have high skin permeability
that decreases their efficacy and maintenance time in the
location. A proper wound dressing can control drug
penetration. Currently, natural polymers have become
more popular due to their nontoxicity, degradability,
biological compatibility, and low cost. Chitosan is one
of the most abundant polysaccharides found in skeletal
materials of crustacean cuticles of insects, crabs,
shrimps, and cell walls of various fungi. It is a cationic
biopolymer that is obtained by N-deacetylation of chitin
[1,5,6]. Chitosan has received great attention for wound
management due to its beneficial intrinsic properties
such as hemostasis, wound healing, bacteriostatic
properties, exudate absorption, and film-forming ability
[7,8]. However, pure chitosan films are brittle and have
poor mechanical strength. Hence, addition of other
polymers is necessary to obtain films with improved
strength and elasticity [2]. Polymers such as poly-
ethylene oxide [9,10], Eudragit [11], and polylactic acid
[12] are used for this purpose. Eudragit RL is a water-
insoluble derivative of acrylate polymers with wide-
spread use in pharmaceutical dosage forms [11].
Eudragit RS and Eudragit RL are neutral copolymers of
poly(ethylacrylate, methyl methacrylate, and trimethy-
lammonioethylmethacrylate chloride). These polymers
are pH independent and capable of swelling. The RL
type of polymer is more permeable to water than the RS
type due to its higher quaternary ammoniumElongation at breakð%ÞZ½increase in length at breaking poconcentration (RS: l/40 ammonium/ester; RL: l/20
ammonium/ester) [13].
The aim of the current study was to design a wound
dressing containing chitosan and Eudragit RL for
controlling the permeation of nitrofurazone cream
(Ubichem, Hampshire, England) (as a highly permeable
drug model) through it.2. Materials and methods
Chitosan, with a deacetylation degree of 97% and
viscosity grade of <25 cp, was purchased from Primex
(Siglufjordur, Iceland), Iceland. Eudragit RL 30D and
propylene glycol were obtained from Rohm Pharma
(Darmstadt, Germany) and Merck (Haar, Germany),
respectively. Nitrofurazone was kindly donated by Najo
Co., Tehran, Iran. All other materials used in this study
were of analytical reagent grade.
2.1. Film preparation
Films were prepared by casting and solvent evapora-
tion. Chitosan solutions (3%)were prepared by dissolving
chitosan in 1.8% acetic acid. Eudragit RL 30D was
diluted using distilled water in order to prepare 0.5%,
1.0%, and 1.5% w/v dispersions, which were added to the
chitosan solutions at a ratio of 1:4 (v/v). In addition,
propylene glycol was added to the mixture as a plasticizer
and agitated for 15 minutes at room temperature. The
mixture was left to stand until air bubbles disappeared.
The resultant mixture was poured onto a dry glass Petri
dish and allowed to dry at 40C for 24 hours. The prepared
films were stored in airtight desiccators containing satu-
rated magnesium nitrate solution (50% relative humidity)
for further studies. Compositions of different formula-
tions of films are shown in Table 1.
2.2. Mechanical properties
The thickness of the filmswasmeasured at five different
places byusing amicrometer. Themechanical properties of
the filmswere evaluated using a texture analyzer (WDW-5;
Berder, China) with a 5 kg load cell. Film specimens
(2  5 cm2) were positioned between two mounting
clamps. The films were pulled by the top clamp at a rate of
10mm/minute. The tensile strength and elongation at break








 sectional area of samplemm2
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Table 1. Compositions of different formulation of films
(v/v ratio).
Formula Chitosan (3%) Eudragit RL Propylene glycol
Cs 4 0 0.1
Cs Eu 0.5 4 1 (0.5%) 0.1
Cs Eu 1 4 1 (1%) 0.1
Cs Eu 1.5 4 1 (1.5%) 0.1
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The test of oxygen permeability through films was
carried out by placing the films on top of open 250 mL
flasks (test area: 1.075  103 m2) containing deionized
water. The test flasks were placed under constant
agitation for 24 hours. The negative control was the
closed flask with an airtight cap (preventing oxygen
from entering the flask), while the positive control was
the open flask (allowing oxygen to enter the flask). The
dissolved oxygen was analyzed according to the Win-
kler’s method. Oxygen permeability (g/m2.day) was
defined as the amount of oxygen penetration through the
film during 24 hours [15].
2.4. Water uptake (swelling)
First, pieces of the films (2  2 cm2) were dried in an
oven at 60C and weighed accurately. Then, they were
immersed in 50 mL buffer phosphate (pH 7.4) at 37C
for 48 hours. The swollen samples were withdrawn from
the medium and weighed after the removal of excess
surface water by a filter paper. The swelling behavior of
the films was assessed as follows:
Water uptakeð%ÞZ½ðWs WiÞ=Wi  100 ð3Þ
where Ws and Wi are the swollen film and the initial dry
film weights, respectively.
2.5. Water vapor transmission rate
The films were cut and placed in sealed test tubes
containing 5 g CaCl2, and were placed in an oven at
60C. The tubes were stored in a desiccator containing
500 mL saturated solution of NaCl (75% relative hu-
midity). After 0 day, 1 day, 2 days, 3 days, 4 days, and 5
days, weights of tubes were determined. Then graphs of
increase in weight with respect to time were plotted, and
water vapor transmission rate (WVTR) (g/m2.day) was
calculated using the following equation:
WVTRZslope=film area ð4Þ
2.6. Nitrofurazone permeability
Permeability of the model drug across the films was
determined using a diffusion cell. The film was mounted
in a Franz-type diffusion cell. Nitrofurazone cream(0.2%; 1.2 g) was applied on the film. An aliquot of
3 mL of the sample was withdrawn from the receptor
compartment (phosphate buffer, pH 7.4) at a pre-
determined time and replaced by the same volume of
fresh phosphate buffer to keep the volume constant. The
concentration of released drug was assayed using a UV
spectrophotometer (Biowave II; Biochrom, Cambridge,
England) at 377 nm. The rate of drug permeation via
skin can be determined using the Fick’s first law
[equations (5)e(7)]. According to this law, the amount
of drug (M ) flowing through a unit cross-sectional area
(S ) of a barrier and appearing in the receptor solution in




where D is the diffusion coefficient of the drug in the
barrier, h denotes the diffusional path length or the film
thickness, K is the partition coefficient of drug between
the film and the receptor medium, C0 stands for the
applied drug concentration that was assumed to be
constant during the experiment, and P is the perme-
ability coefficient of the drug through the film.
The flux, J, was determined from the slope of the
steady-state portion of the amount of drug permeated
divided by S versus time. Lag time values were deter-
mined from the x-intercept of the linear region at steady
state.
2.7. Statistical analysis
All data were expressed as mean  standard devia-
tion. Statistical analysis of data was performed using
one-way analysis of variance. Statistical significance
was associated with a probability of p < 0.05. All ex-
periments were carried out in triplicate.3. Results
A suitable film for wound dressing should be strong
and to some extent flexible [5]. The thickness, tensile
strength, and elongation at break of the films are shown
in Table 2. These results indicated that the tensile
strength of the chitosan films decreased with inclusion
of Eudragit RL (p < 0.05). However, by increasing the
Eudragit RL content of composite films, the thickness
and tensile strength of the films were enhanced, but their
elongation was decreased. The films with Eudragit RL
1.5% showed the highest strength and the lowest elon-
gation properties compared with the other films
(p < 0.05). It is known that there is an inverse rela-
tionship between tensile strength and elongation of
biopolymer films [5]. Our results are similar to the
Table 2. Mechanical properties of Cs films (mean  SD, n Z 3).
Formula Thickness (mm) Tensile strength (MPa) Elongation (%)
Cs 94  11.40 25  4.25 20.873  0.69
Cs Eu 0.5 104  11.40 10.73  1.54 12.18  0.99
Cs Eu 1 130  15.81 14.36  0.80 9.634  0.19
Cs Eu 1.5 156  8.94 17.31  2.56 7.93  0.40
SD Z standard deviation.
Table 3. Value of water uptake and WVTR in different
formulations.
Formula Water uptake 48 h (%) WVTR (g/m2 d)
Cs 108.18  1.61 205.63  9.90
Cs Eu 0.5 112.74  0.90 201.30  0.00
Cs Eu 1 111.56  2.77 205.63  9.92
Cs Eu 1.5 116.70  2.39 214.29  6.5
WVTR Z water vapor transmission rate.
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chitosaneEudragit RS 30D as wound dressings. Ac-
cording to their results, elongation was reduced by
enhancing the concentration of Eudragit RS 30D (0.5%,
1%, and 1.5%).Our findings imply that increasing the
density of the films by increasing the total solid content
reduced their flexibility. High elasticity of chitosan films
makes their handling and application as wound dress-
ings difficult. However, elongation at break reduces with
the addition of Eudragit RL. Mechanical properties of
the composite films with lower elongation at break and
reasonable tensile strength values suggest that they have
high potential to be used in medical applications.
Oxygen penetration all of formulation was signifi-
cantly different with positive and negative controls
(p < 0.05) (Figure 1). It can be concluded that oxygen
was able to penetrate through all the film formulations.
It is believed that the presence of propylene glycol in
these films helps in the movement of polymer chains, to
allow the passage of oxygen molecules [16e18]. Oxy-
gen penetration did not differ significantly among the
composite films. These results are similar to the findings
of Wittaya-areekul et al [15]. According to their results,
oxygen penetration into the films with various Eudragit
RS contents was somewhat similar.
Water uptake values and the WVTRs in different
formulations are summarized in Table 3. The water
uptake values indicated that all films had water retention
capability, and no significant difference was observed
between chitosan films and the films containing different
concentrations of Eudragit RL. Our finding is contrary to
the results of Wittaya-areekul et al [15], which showed
the chitosan films had the highest water uptake values,Figure 1. OP through different formulations (mean  SD,
nZ 3). OPZ oxygen permeability; SDZ standard deviation.while the presence of Eudragit RS reduced their
swelling ability, although no significant difference was
observed between the films containing various concen-
trations of Eudragit RS (0.5%, 1%, and 1.5%). Eudragit
RL and Eudragit RS are acrylic and methacrylic acid
esters with some hydrophilic properties due to the
presence of quaternary ammonium groups. Eudragit RL
contains a higher amount of such groups, and hence its
water permeability is higher than that of Eudragit RS
[19]. Owing to this property, the presence of Eudragit
RL (in this concentration range) does not lead to
lowering of water uptake by the composite films in
comparison with the chitosan films. However, the ability
of a film to preserve water is one of the most important
aspects in skin tissue engineering, especially for wound
healing [20]. Water-uptake capacity of a wound dressing
should be considerably high for rapid absorption of
exudates [21].Figure 2. Profile of nitrofurazone permeability of different
formulations.
Table 4. Values of flux (J ), permeability coefficient (P), and drug release for each formulation after 24 hours (R24).
Formula J (mg/cm2 h) P (cm/h) R24 (%)
Cs 0.004  0.0004 0.0019  0.0002 19.874  3.125
Cs Eu 0.5 0.022  0.0001 0.0112  0.000 44.478  0.333
Cs Eu 1 0.009  0.0001 0.0044  0.000 27.435  0.331
Cs Eu 1.5 0.008  0.0001 0.0038  0.000 26.125  0.159
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It was reported that permeability of moisture through
the film is important for wound dressing, to keep the
wound moist and comfortable, to help in the healing
process [5]. An ideal dressing must be permeable to the
extent that moist exudates under the dressing are
maintained, to inhibit excess fluid absorption and
evaporation leading to desiccation of the wound bed
[14]. The rate of water vapor transmission through all
films was partly high. Chitosan has good hydrophilic
characteristics. It is well known that the hydrophilic
nature of a polymer membrane induces water vapor
tendency and increases the WVTR [22]. The results
demonstrated that the WVTR was not affected by
different concentrations of Eudragit RL or by different
thicknesses of films (p > 0.05). As mentioned in the
section on mechanical strength, the presence of Eudragit
RL in the chitosan films led to decreases of integrity and
strength of intermolecular forces in the primary structure
of chitosan. This phenomenon can facilitate permeation
of water. Besides, it is expected that an increase in the
film thickness decreases the WVTR due to an increase in
the total solid content. It seems that simultaneous
occurrence of these two phenomena led to the same
WVTR values in the presence of different concentra-
tions of Eudragit RL 100.
The profile of nitrofurazone permeability of different
formulations is shown in Figure 2, and the values of flux
(J ) and KP are presented in Table 4.
According to the results, permeability of chitosan
films increased with the inclusion of Eudragit RL in
composite films (p < 0.05). Eudragit RL causes the
network of cross-linked chitosan to discontinue and re-
duces the integrity of the films, facilitating the diffusion
of nitrofurazone through the films. Of course by an in-
crease in the concentration of Eudragit RL, the perme-
ation rate of drug through the films is decreased
(p < 0.05). This decrease might be a result of the
enhancement of the total solid content and thickness of
composite films with the higher ratios of Eu:Cs. In this
study, chitosan films with the lowest content of Eudragit
RL (0.5%) exhibited the highest and most acceptable
level of drug release (44.478%) after 24 hours.
This study revealed that Eudragit RL can be incor-
porated into a chitosan film to improve its mechanicalproperties, while substantially maintaining vapor pene-
tration, water uptake, and oxygen penetration re-
quirements to provide a good wound-healing
environment. The films comprising 3% chitosan and
0.5% Eudragit RL showed the highest amount of drug
release after 24 hours, exhibiting potential to be used as
wound dressings.Conflicts of interest
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